Sustaining Sponsors

Donors making a three-year commitment of $25,000-$49,999 per year. Their generous support is crucial to Keystone Symposia's ability to plan future scientific conferences focused on emerging topics and excellence in science.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Development Office, Email: development@keystonesymposia.org, Phone:+1 970-262-2689

Click here for more information on Industry Support and Recognition Opportunities.
Astellas Pharma Inc. Autolus Therapeutics Bioverativ Therapeutics
BlueRock Therapeutics Boehringer Ingelheim Pharmaceuticals, Inc. Compass Therapeutics
Editas Medicine EMD Serono Research and Development Institute, Inc. Gilead Sciences, Inc.
MedImmune Moderna MorphoSys AG
Novartis Institutes for BioMedical Research Sangamo Therapeutics, Inc. Sanofi US
Shire Surface Oncology TESARO, Inc.
Thermo Fisher Scientific Inc.    



Sponsors

Donors contributing $25,000-$49,999. These generous gifts allow us to convene meetings in a wide variety of important areas, many of which are in the early stages of research. Special thanks to these organizations for consistent, annual Sponsor-level support.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Development Office, Email: development@keystonesymposia.org, Phone:+1 970-262-2689

Click here for more information on Industry Support and Recognition Opportunities.
AbbVie Inc. Akebia Therapeutics Allen Institute
AstraZeneca Biogen Bristol-Myers Squibb Company
Burroughs Wellcome Fund Educational grant from Celgene Corporation Genmab A/S
GlaxoSmithKline ImmunoGen, Inc. Ionis Pharmaceuticals, Inc.
Janssen R&D: Pharmaceutical Companies of Johnson & Johnson Educational grant from Lilly MacroGenics, Inc.
Sarepta Therapeutics Science Foundation Ireland 10x Genomics
Tessa Therapeutics Ltd. Theravance Biopharma Vertex Pharmaceuticals Incorporated